Bristol Myers Squibb Co. (BMY)
67.28
+0.27
(+0.40%)
USD |
NYSE |
Aug 24, 16:00
67.13
-0.15
(-0.22%)
Pre-Market: 20:00
Bristol Myers Squibb Net Income (Quarterly) : 3.316B for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.316B |
| March 31, 2026 | 2.678B |
| December 31, 2025 | 1.086B |
| September 30, 2025 | 2.195B |
| June 30, 2025 | 1.313B |
| March 31, 2025 | 2.462B |
| December 31, 2024 | 76.00M |
| September 30, 2024 | 1.215B |
| June 30, 2024 | 1.684B |
| March 31, 2024 | -11.91B |
| December 31, 2023 | 1.762B |
| September 30, 2023 | 1.934B |
| June 30, 2023 | 2.077B |
| March 31, 2023 | 2.267B |
| December 31, 2022 | 2.025B |
| September 30, 2022 | 1.608B |
| June 30, 2022 | 1.429B |
| March 31, 2022 | 1.283B |
| December 31, 2021 | 2.372B |
| September 30, 2021 | 1.552B |
| June 30, 2021 | 1.061B |
| March 31, 2021 | 2.029B |
| December 31, 2020 | -10.03B |
| September 30, 2020 | 1.878B |
| June 30, 2020 | -80.00M |
| Date | Value |
|---|---|
| March 31, 2020 | -766.00M |
| December 31, 2019 | -1.06B |
| September 30, 2019 | 1.366B |
| June 30, 2019 | 1.439B |
| March 31, 2019 | 1.715B |
| December 31, 2018 | 1.19B |
| September 30, 2018 | 1.912B |
| June 30, 2018 | 382.00M |
| March 31, 2018 | 1.495B |
| December 31, 2017 | -2.329B |
| September 30, 2017 | 856.00M |
| June 30, 2017 | 922.00M |
| March 31, 2017 | 1.526B |
| December 31, 2016 | 898.00M |
| September 30, 2016 | 1.215B |
| June 30, 2016 | 1.188B |
| March 31, 2016 | 1.206B |
| December 31, 2015 | -129.00M |
| September 30, 2015 | 730.00M |
| June 30, 2015 | -110.00M |
| March 31, 2015 | 1.199B |
| December 31, 2014 | 27.00M |
| September 30, 2014 | 732.00M |
| June 30, 2014 | 334.00M |
| March 31, 2014 | 936.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
| Merck & Co., Inc. | -1.337B |
| Pfizer Inc. | -246.00M |
| AstraZeneca PLC | 3.076B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 12.98B |
| Total Expenses (Quarterly) | 9.665B |
| EPS Diluted (Quarterly) | 1.620 |
| Enterprise Value | 171.44B |
| Gross Profit Margin (Quarterly) | 67.95% |
| Profit Margin (Quarterly) | 25.54% |
| Earnings Yield | 6.75% |
| Operating Earnings Yield | 11.58% |
| Normalized Earnings Yield | 9.130 |